Differential effects of SB 242235, a selective p38 mitogen-activated protein kinase inhibitor, on IL-1 treated bovine and human cartilage/chondrocyte cultures.

Badger, A M; Roshak, A K; Cook, M N; Newman-Tarr, T M; Swift, B A; Carlson, K; Connor, J R; Lee, J C; Gowen, M; Lark, M W; Kumar, S

Badger, A M; Roshak, A K; Cook, M N; Newman-Tarr, T M; Swift, B A; Carlson, K; Connor, J R; Lee, J C; Gowen, M; Lark, M W; Kumar, S.

Affiliation

Badger AM; Department of Bone and Cartilage Biology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406, USA. Alison_M_Badger@SBPHRD.com

Osteoarthritis Cartilage ; 8(6): 434-43, 2000 Nov.

Article de En | MEDLINE | ID: mdl-11069728

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pyridines / Interleukine-1 / Chondrocytes / Mitogen-Activated Protein Kinases / Antienzymes / Imidazoles Limites: Animals / Humans Langue: En Journal: Osteoarthritis Cartilage Sujet du journal: ORTOPEDIA / REUMATOLOGIA Année: 2000 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links